Alain Kirchmeyer
Chief Executive Officer at Cenexi Services SAS
Profile
Alain Kirchmeyer is currently the Chief Executive Officer at Cenexi Services SAS and the President at Phixen SAS.
He previously worked as the Chief Executive Officer at Delpharm Industrie SAS.
Alain Kirchmeyer active positions
| Companies | Position | Start |
|---|---|---|
Phixen SAS
 Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million. | President | 2024-02-26 |
Cenexi Services SAS
 Cenexi Services SAS Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi Services SAS is a French company that provides contract development and manufacturing services for pharmaceutical companies. The company is based in Fontenay-sous-Bois, France. The company was founded in 2010. Alain Kirchmeyer has been the CEO of the company since 2024. | Chief Executive Officer | 2024-03-31 |
Former positions of Alain Kirchmeyer
| Companies | Position | End |
|---|---|---|
Delpharm Industrie SAS
 Delpharm Industrie SAS BiotechnologyHealth Technology Delpharm Industrie SAS engages in the manufacture and development of CDMO drugs. It produces dosage forms, non-sterile and sterile liquids, solids, semi-solids and biotech products. The company was founded in 1988 and is headquartered in Boulogne-Billancourt, France. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Phixen SAS
Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million. | Finance |
Delpharm Industrie SAS
Delpharm Industrie SAS BiotechnologyHealth Technology Delpharm Industrie SAS engages in the manufacture and development of CDMO drugs. It produces dosage forms, non-sterile and sterile liquids, solids, semi-solids and biotech products. The company was founded in 1988 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Cenexi Services SAS
Cenexi Services SAS Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi Services SAS is a French company that provides contract development and manufacturing services for pharmaceutical companies. The company is based in Fontenay-sous-Bois, France. The company was founded in 2010. Alain Kirchmeyer has been the CEO of the company since 2024. | Health Technology |
- Stock Market
- Insiders
- Alain Kirchmeyer
